Home About us Contact
|
Home About us Contact | ||
|
|
||
Publications
Kinds of Publications Terms modified by Publications Selected AbstractsFEDERAL RESERVE TRANSCRIPT PUBLICATION AND REGIONAL REPRESENTATIONCONTEMPORARY ECONOMIC POLICY, Issue 2 2010ELLEN E. MEADE This article looks at disagreement within the Federal Reserve's monetary policy committee, the Federal Open Market Committee or FOMC, following a change in transparency practices taken in 1993 to publish verbatim transcripts of FOMC meetings. Other literature has examined the effects of opening the FOMC's deliberations to public view and provided empirical evidence that the publication of transcripts made policymakers less willing to voice disagreement with the chairman's policy proposal. This article adds to that work by examining whether regional variables are important to the analysis and whether the transcription effects are robust to the inclusion of regional variables. The results indicate that transcription effects are indeed robust, regardless of the regional indicator used, and that larger Federal Reserve districts may be more likely to voice agreement with a given policy proposal. (JEL E42, E58, E65, F33) [source] SUCCESS, TRUTH, AND MODERNISM IN HOLOCAUST HISTORIOGRAPHY: READING SAUL FRIEDLÄNDER THIRTY-FIVE YEARS AFTER THE PUBLICATION OF METAHISTORY,HISTORY AND THEORY, Issue 2 2009WULF KANSTEINER ABSTRACT This essay provides a close reading of Saul Friedländer's exceptionally successful comprehensive history of the Holocaust from the theoretical perspective of Hayden White's philosophy of history. Friedländer's The Years of Extermination has been celebrated as the first synthetic history of the "Final Solution" that acknowledges the experiences of the victims of Nazi genocide. But Friedländer has not simply added the voices of the victims to a conventional historical account of the Holocaust. Instead, by displacing linear notions of time and space and subtly deconstructing conventional concepts of causality, he has invented a new type of historical prose that performs rather than analyzes the victims' point of view. Friedländer's innovation has particularly radical consequences for the construction of historical explanations. On the one hand, Friedländer explicitly argues that anti-Semitism was the single most important cause of the Holocaust. On the other hand, his transnational, multifaceted history of the "Final Solution" provides a wealth of data that escapes the conceptual grasp of his explicit model of causation. Friedländer chooses this radically self-reflexive strategy of historical representation to impress on the reader the existential sense of disbelief with which the victims experienced Nazi persecution. To Friedländer, that sense of disbelief constitutes the most appropriate ethical response to the Holocaust. Thus the narratological analysis of The Years of Extermination reveals that the exceptional quality of the book, as well as presumably its success, is the result of an extraordinarily creative act of narrative imagination. Or, put into terms developed by White, who shares Friedländer's appreciation of modernist forms of writing, The Years of Extermination is the first modernist history of the Holocaust that captures, through literary figuration, an important and long neglected reality of the "Final Solution." [source] MESSAGE FROM THE EDITOR: PUBLICATION OF PAPERS FROM THE SYMPOSIUM "BORROWED CHLOROPLASTS: SECONDARY ENDOSYMBIOSIS AND THE CHROMALVEOLATES"JOURNAL OF PHYCOLOGY, Issue 1 2008Robert G. Sheath No abstract is available for this article. [source] SHORT COMMUNICATION: ACCELERATED PUBLICATION: Diode characteristics in state-of-the-art ZnO/CdS/Cu(In1,xGax)Se2 solar cells,PROGRESS IN PHOTOVOLTAICS: RESEARCH & APPLICATIONS, Issue 3 2005Miguel A. Contreras Abstract We report a new state of the art in thin-film polycrystalline Cu(In,Ga)Se2 -based solar cells with the attainment of energy conversion efficiencies of 19·5%. An analysis of the performance of Cu(In,Ga)Se2 solar cells in terms of some absorber properties and other derived diode parameters is presented. The analysis reveals that the highest-performance cells can be associated with absorber bandgap values of ,1·14,eV, resulting in devices with the lowest values of diode saturation current density (,3×10,8,mA/cm2) and diode quality factors in the range 1·30,<,A,<,1·35. The data presented also support arguments of a reduced space charge region recombination as the reason for the improvement in the performance of such devices. In addition, a discussion is presented regarding the dependence of performance on energy bandgap, with an emphasis on wide-bandgap Cu(In,Ga)Se2 materials and views toward improving efficiency to >,1;20% in thin-film polycrystalline Cu(In,Ga)Se2 solar cells. Published in 2005 John Wiley & Sons, Ltd. [source] PUBLICATION ETHICS AND THE GHOST MANAGEMENT OF MEDICAL PUBLICATIONBIOETHICS, Issue 6 2010SERGIO SISMONDO ABSTRACT It is by now no secret that some scientific articles are ghost authored , that is, written by someone other than the person whose name appears at the top of the article. Ghost authorship, however, is only one sort of ghosting. In this article, we present evidence that pharmaceutical companies engage in the ghost management of the scientific literature, by controlling or shaping several crucial steps in the research, writing, and publication of scientific articles. Ghost management allows the pharmaceutical industry to shape the literature in ways that serve its interests. This article aims to reinforce and expand publication ethics as an important area of concern for bioethics. Since ghost-managed research is primarily undertaken in the interests of marketing, large quantities of medical research violate not just publication norms but also research ethics. Much of this research involves human subjects, and yet is performed not primarily to increase knowledge for broad human benefit, but to disseminate results in the service of profits. Those who sponsor, manage, conduct, and publish such research therefore behave unethically, since they put patients at risk without justification. This leads us to a strong conclusion: if medical journals want to ensure that the research they publish is ethically sound, they should not publish articles that are commercially sponsored. [source] X. THE "HISTORY" OF TWO MILESTONE DEVELOPMENTAL PUBLICATIONS ON BLACK CHILDRENMONOGRAPHS OF THE SOCIETY FOR RESEARCH IN CHILD DEVELOPMENT, Issue 1 2006Margaret Beale Spencer First page of article [source] REDUNDANT PUBLICATIONS: A CAUTIONARY TALEANZ JOURNAL OF SURGERY, Issue 4 2008John C. Hall Editor-in-Chief No abstract is available for this article. [source] Notice of Dual PublicationDERMATOLOGIC SURGERY, Issue 10 2002Article first published online: 4 NOV 200 No abstract is available for this article. [source] Role of meta-analysis of clinical trials for Alzheimer's diseaseDRUG DEVELOPMENT RESEARCH, Issue 3 2002Jesús M. López Arrieta Abstract Alzheimer's disease (AD) is a growing worldwide medical, social, and economic problem. In all countries, both prevalence and incidence of this disorder increase with age. The task of translating scientific clinical research into effective interventions for dementia has proved to be a difficult challenge. Data about the effects of therapeutic interventions come from several sources of evidence, ranging from studies with little potential for systematic bias and minimal random error, such as well-designed randomized controlled trials, through controlled but nonrandomized cohort and case-control studies, all the way to opinions based on laboratory evidence or theory. Although clinical trials are widespread in AD, there is increasing recognition that the results of studies do not necessarily apply to the type of patients that are seen by clinicians because of differences in patient characteristics, comorbidities, cotherapies, severity of disease, compliance, local circumstances, and patients preferences, which may differ sufficiently from those in the trial situation to attenuate or change the benefit-to-risk ratio. There are several methods to address those issues, like pragmatic trials and n-of-1 trials. When data from randomized clinical trials do not provide clear answers from sufficiently similar studies in the magnitude of effect sizes, lack of statistical significance, or identification of subgroups, systematic reviews and meta-analysis may help to provide a better summary of the data. A major difference between a traditional review and a systematic is the systematic nature in which studies are chosen and appraised. Traditional reviews are written by experts in the field who use differing and often subjective criteria to decide what studies to include and what weight to give them, and hence the conclusions are often very diverse, depending on the reviewer. Publication and selection bias is a major concern of traditional reviews. Systematic reviews and meta-analysis are being increasingly used in dementia, propelled by the Cochrane Dementia and Cognitive Improvement Group, to make decisions about treatment, management, and care and to guide future research. This narrative review describes the rationale for randomized clinical trials and systematic reviews in dementia, particularly AD. Drug Dev. Res. 56:401,411, 2002. © 2002 Wiley-Liss, Inc. [source] Peer-Reviewed Publication: A View from InsideEPILEPSIA, Issue 8 2004Robert S. Fisher First page of article [source] ,Aus so prosaischen Dingen wie Kartoffeln, Straßen, Traktoren werden poetische Dinge!': Brecht, Sinn und Form, and Strittmatter's KatzgrabenGERMAN LIFE AND LETTERS, Issue 1 2003Matthew Philpotts This article takes as its starting,point an essay written by Bertolt Brecht in praise of the GDR playwright Erwin Strittmatter and his Socialist Realist drama, Katzgraben, which was staged by the Berliner Ensemble in May 1953. Published in the late summer of 1953 in Sinn und Form, this rather neglected essay is of significance because Brecht adopts in it a highly orthodox GDR position at a time when he was otherwise making dissenting interventions in GDR cultural politics. Publication of the essay, at a time when political pressure on Brecht had eased, is evidence that his interest in Strittmatter's play was not merely a short,term tactical manoeuvre to placate the SED regime. Rather, it was part of a consistent belief in the necessity of demonstrating what Brecht perceived to be the genuine achievements of the GDR. The events of 17 June, and the fascist mindset which Brecht saw underlying them, only served to reinforce this necessity in his mind. Brecht's pre,occupation with Katzgraben has a broader significance in highlighting the tendency in Brecht criticism to over,privilege tactical explanations for his behaviour in the GDR and in demonstrating that his cultural,political dissent was vitiated all the time by consistent ideological assent. [source] Frovatriptan and Data PublicationHEADACHE, Issue 9 2008Dr Med Sci, Peer Tfelt-Hansen MD No abstract is available for this article. [source] Publication of clinical trials: accountability and accessibilityJOURNAL OF INTERNAL MEDICINE, Issue 4 2004M. B. Tumber Abstract. Publication of findings from clinical trials is a necessary step in the research continuum, to provide a record of the work done, convey information to the community, and support translation of research into clinical practice. Systematic reviews of randomized controlled trials are now widely regarded as the highest level of evidence in determining the effect of an intervention on an outcome. They largely depend on internationally accessible, published reports of all trials undertaken. Investigators and their institutions or organizations have responsibility for reporting their clinical trials accurately and completely, including disclosure of potential conflicts of interest. To ensure evidence-based health care, issues relating to accessibility and accountability of clinical trial results require immediate action. [source] What Every Author Should Know About Redundant and Duplicate PublicationJOURNAL OF NURSING SCHOLARSHIP, Issue 4 2005Sue T. Hegyvary Editor [source] Manuscripts Accepted for PublicationJOURNAL OF RESEARCH ON ADOLESCENCE, Issue 4 2009Article first published online: 19 NOV 200 [source] The Path to Publication: Manuscript Management and Peer ReviewJOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, Issue 3 2000Charon A. Pierson No abstract is available for this article. [source] Publication of the Journal of Veterinary Internal MedicineJOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 1 2008K.W. Hinchcliff No abstract is available for this article. [source] Editorial: JVIM Online Submission, Review, and PublicationJOURNAL OF VETERINARY INTERNAL MEDICINE, Issue 1 2005Kenneth W. Hinchcliff No abstract is available for this article. [source] Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habitsALIMENTARY PHARMACOLOGY & THERAPEUTICS, Issue 3 2002H. J. O'Connor Background: Consensus guidelines have been published on the management of Helicobacter pylori infection and it is assumed that these guidelines are adhered to in clinical practice. Aim: To assess the changing attitudes of medical practitioners to H. pylori, and the impact of H. pylori infection on everyday clinical practice and prescribing patterns. Methods: Data for this review were gathered up to December 2000 from detailed review of medical journals, the biomedical database MEDLINE, and relevant abstracts. Results: Physician surveys show widespread acceptance of H. pylori as a causal agent in peptic ulcer disease. Gastroenterologists adopted H. pylori therapy for peptic ulcer earlier and more comprehensively than primary care physicians. Despite a low level of belief in H. pylori as a causal agent in nonulcer dyspepsia and gastro-oesophageal reflux disease (GERD), H. pylori therapy is widely prescribed for these conditions. Proton pump inhibitor-based triple therapy is the eradication regimen of choice by all physician groups. In routine clinical practice, there appears to be significant under-treatment of peptic ulcer disease with H. pylori therapy, but extensive use for nonulcer indications. Prescription of H. pylori treatment regimens of doubtful efficacy appears commonplace, and are more likely in primary care. Despite the advent of H. pylori therapy, the prescription of antisecretory therapy, particularly of proton pump inhibitors, continues to rise. Conclusions: Publication of consensus guidelines per se is not enough to ensure optimal management of H. pylori infection. Innovative and ongoing educational measures are needed to encourage best practice in relation to H. pylori infection. These measures might be best directed at primary care, where the majority of dyspepsia is managed. [source] Strategies for Managing Barriers to the Writing ProcessNURSING FORUM, Issue 4 2000Celia E. Wills RN Publication is essential to advancing nursing knowledge for clinical practice, but relatively few nurses publish the results of their research or other writings about clinical practice issues. This article identifies some common barriers to writing for publication-personal factors, such as inadequate knowledge and writing skills, lack of confidence, and low motivation for writing for publication; and situational factors, such as limited time, energy, and other resources constraints-and discusses strategies for managing such barriers. Key words: [source] Guidelines for submitting adverse event reports for publication,,PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Issue 5 2007FISPE (Chair), William N. Kelly Pharm D Publication of case reports describing suspected adverse effects of drugs and medical products that include herbal and complementary medicines, vaccines, and other biologicals and devices is important for postmarketing surveillance. Publication lends credence to important signals raised in these adverse event reports. Unfortunately, deficiencies in vital information in published cases can often limit the value of such reports by failing to provide sufficient details for either (i) a differential diagnosis or provisional assessment of cause-effect association, or (ii) a reasonable pharmacological or biological explanation. Properly described, a published report of one or more adverse events can provide a useful signal of possible risks associated with the use of a drug or medical product which might warrant further exploration. A review conducted by the Task Force authors found that many major journals have minimal requirements for publishing adverse event reports, and some have none at all. Based on a literature review and our collective experience in reviewing adverse event case reports in regulatory, academic, and industry settings, we have identified information that we propose should always be considered for inclusion in a report submitted for publication. These guidelines have been endorsed by the International Society for Pharmacoepidemiology (ISPE) and the International Society of Pharmacovigilance (ISoP) and are freely available on the societies' web sites. Their widespread distribution is encouraged. ISPE and ISoP urge biomedical journals to adopt these guidelines and apply them to case reports submitted for publication. They also encourage schools of medicine, pharmacy, and nursing to incorporate them into the relevant curricula that address the detection, evaluation, and reporting of suspected drug or other medical product adverse events. Copyright © 2007 Kelly et al. Reproduced with permission by John Wiley & Sons, Ltd. [source] Righting Wrongs: John Henry Ingram's First Publication on PoePOE STUDIES, Issue 1-2 2001David Degener First page of article [source] On the Publication of the English Journal of the Japanese Psychogeriatric SocietyPSYCHOGERIATRICS, Issue 1 2001Masatoshi Takeda No abstract is available for this article. [source] The Controversies over the Publication of Ariel Toaff's "Bloody Passovers",THE JOURNAL OF THE HISTORICAL SOCIETY, Issue 4 2008Sabina Loriga [source] Standards for Ethical PublicationTHE LARYNGOSCOPE, Issue 1 2007Jonas T. Johnson MD No abstract is available for this article. [source] Priority In Medical PublicationTHE LARYNGOSCOPE, Issue 4 2004Jonas T. Johnson MD No abstract is available for this article. [source] The Continued Electronic Evolution of Medical Publishing: Artificial Organs Now Offers E-Only Publication!ARTIFICIAL ORGANS, Issue 1 2010Hillary Bixby No abstract is available for this article. [source] Artificial Organs Begins 30th Year of PublicationARTIFICIAL ORGANS, Issue 1 2006Paul S. Malchesky D.Eng. No abstract is available for this article. [source] Publication and citation statistics for UK astronomersASTRONOMY & GEOPHYSICS, Issue 6 2007Alexander Blustin First page of article [source] Oral medicine in Australia 2000,2010.AUSTRALIAN DENTAL JOURNAL, Issue 2010A publications overview Abstract Specialties within health care are often identified by the public profile provided by members within the private clinical practice arena. This is clearly important but often the real activity of a specialty discipline exists within the training institutions. This is an unseen area for most, both members of the public as well as professional colleagues, as papers reporting developments of all kinds are delivered to highly specific target audiences and publications reporting research are published in journals again targeting specific audiences. Publication in national journals is important and provides a glimpse of research activities and a wealth of clinical material in the form of reviews and case reports directed again to a specific target audience. This paper addresses the profile of oral medicine in Australia by presenting the papers published in the Australian Dental Journal within a 10-year bracket. [source] | |||||||||||||||||||||||||||||||||||||||||||||||||